ArticleFrontiers in immunology2026

An integrated analysis of SLC7A11 as a pan-cancer immunotherapeutic biomarker with experimental validation of its regulation by miR-148b-3p in breast cancer.

Songchen Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.